Clinical trials
Phase 1 Tobacco Use Disorder trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
96 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 8 |
| 2010 | 3 |
| 2011 | 7 |
| 2012 | 5 |
| 2013 | 4 |
| 2014 | 5 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 8 |
| 2018 | 6 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 8 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 77 |
| Recruiting | 9 |
| Withdrawn | 5 |
| Unknown status | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yale University | 19 |
| National Institute on Drug Abuse (NIDA) | 6 |
| Johns Hopkins University | 5 |
| Duke University | 4 |
| McNeil AB | 4 |
| Pierre Fabre Medicament | 4 |
| GlaxoSmithKline | 3 |
| Star Scientific, Inc | 3 |
| Wake Forest University Health Sciences | 3 |
| Boston Children's Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tobacco Use Disorder | 96 |
| Substance-Related Disorders | 7 |
| Alcoholism | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Marijuana Abuse | 2 |
| Amphetamine-Related Disorders | 1 |
| Breast Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
| Disease Attributes | 1 |
| Disorders of Environmental Origin | 1 |
Trials
Showing 26 to 50 of 96. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.